Physician profile
Katherine E Johnson
NPI 1891999272
$6,203.76
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $4,875 · 2021: $402 · 2022: $253 · 2023: $69.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $69.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $69.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $5,063.57 | 2019-2020 | |
| Alcon Vision LLC | $543.91 | 2019-2023 | Clareon |
| Regeneron Healthcare Solutions, INC. | $205.90 | 2019-2022 | |
| New World Medical,INC. | $76.43 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $76.34 | 2019-2020 | |
| Allergan, INC. | $71.45 | 2019-2022 | |
| Genentech USA, INC. | $63.04 | 2022 | |
| Kala Pharmaceuticals, INC. | $43.13 | 2019 | |
| Shire North American Group INC | $32.36 | 2019 | |
| Oyster Point Pharma, INC. | $27.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.